Lupin Ltd. | LUPIN | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Net Income
Net Income
15,172
8,768
16,765
-13,722
7,165
Cash flow Operating Act...
Cash flow Operating Activities
16,66014,68818,2183,67318,972
Investments in PPE
Investments in PPE
-9,854-6,731-6,776-9,051-14,996
Cash flow Investing Act...
Net cash used for Investment Activities
-32,82511,070-12,39612,922-12,868
Dividend Paid
Dividend Paid
2,7132,7302,7232,9511,825
Cash flow Financing Act...
Net cash provided by Financing Activities
7,441-8,906-18,853-15,723-3,373
Cash at beginning of period
Cash at beginning of period
14,1645,44122,2939,2629,914
Cash at end of period
Cash at end of period
5,44122,2939,26210,13412,646
Free Cash Flow
Free Cash Flow
6,806
7,957
11,441
-5,378
3,976